Mechanism of action of flavonoids in prevention of inflammation-associated skin cancer

Current Medicinal Chemistry

Volumn 23, Issue 32, 2016, Pages 3697-3716

  George, Vazhappilly Cijo ^a   Vijesh, Vijayabhavanath Vijayakumaran ^b   Amararathna, Dehigaspege Inoka Madumani ^a   Lakshmi, Chelakkot Ayshwarya ^c   Anbarasu, Kannan ^d   Kumar, Devanga Ragupathi Naveen ^e   Ethiraj, Kannatt Radhakrishnan ^f   Kumar, Rangasamy Ashok ^g   Vasantha Rupasinghe, H P ^a,h  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Dr GR Damodaran College of Science   (India)

^c MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^e CHRISTIAN MEDICAL COLLEGE   (India)

^f VIT UNIVERSITY   (India)

^g GOVERNMENT ARTS COLLEGE   (India)

^h DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Chemoprevention; Flavonoids; Inflammation; Mechanism of action; Melanoma; Skin cancer

Indexed keywords

APIGENIN; BETA CATENIN; BETA LAPACHONE; CASPASE 14; CHRYSIN; DIHYDROMYRICETIN; EPIGALLOCATECHIN GALLATE; EUPAFOLIN; FILAGGRIN; FISETIN; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; GELATINASE B; ISOFLAVONE DERIVATIVE; KAEMPFEROL; LUTEOLIN; MICRORNA; MICRORNA 203; PROANTHOCYANIDIN; QUERCETIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CANCER INCIDENCE; CANCER PREVENTION; CELL CYCLE REGULATION; CELL KILLING; CHEMOPROPHYLAXIS; DIET; DNA REPAIR; DRUG MECHANISM; ECZEMA; HUMAN; INFLAMMATION; MELANOMA; MELANOMA SKIN CANCER; METASTASIS INHIBITION; MOLECULARLY TARGETED THERAPY; NON MELANOMA SKIN CANCER; REVIEW; SKIN CANCER; ULTRAVIOLET B RADIATION;

EID: 84995892106     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867323666160627110342     Document Type: Review

References (169)

1. Hoste, E.; Denecker, G.; Gilbert, B.; Van Nieuwerburgh, F.; van der Fits, L.; Asselbergh, B.; De Rycke, R.; Hachem, JP.; Deforce, D.; Prens, E.P.; Vandenabeele, P.; Declercq, W. Caspase-14-deficient mice are more prone to the development of parakeratosis. J. Invest. Dermatol., 2013, 133(3), 742-750.
2. Oranges, T.; Dini, V.; Romanelli, M. Skin physiology of the neonate and infant: clinical implications. Adv. Wound Care (New Rochelle), 2015, 4(10), 587-595.
3. Eckhart, L.; Lippens, S.; Tschachler, E.; Declercq, W. Cell death by cornification. Biochimica et Biophysica Acta (BBA). Mol. Cell Res., 2013, 1833(12), 3471-3480.
4. Serafini-Fracassini, D.; Del Duca, S. Transglutaminases: widespread cross-linking enzymes in plants. Ann. Bot. (Lond.), 2008, 102(2), 145-152.
5. Denecker, G.; Ovaere, P.; Vandenabeele, P.; Declercq, W. Caspase-14 reveals its secrets. J. Cell Biol., 2008, 180(3), 451-458.
6. Nickoloff, B.J.; Qin, J.Z.; Chaturvedi, V.; Bacon, P.; Panella, J.; Denning, M.F. In: Journal of Investigative Dermatology Symposium Proceedings; Nature Publishing Group, 2002; Vol. 7, pp. 27-35.
7. Lippens, S.; Hoste, E.; Vandenabeele, P.; Agostinis, P.; Declercq, W. Cell death in the skin. Apoptosis, 2009, 14(4), 549-569.
8. D'Orazio, J.; Jarrett, S.; Amaro-Ortiz, A.; Scott, T. UV radiation and the skin. Int. J. Mol. Sci., 2013, 14(6), 12222-12248.
9. Ultraviolet radiation and the INTERSUN Programme http://www.who.int/uv/faq/skincancer/en/index1.html
10. Iyama, T.; Wilson, D.M. III DNA repair mechanisms in dividing and non-dividing cells. DNA Repair (Amst.), 2013, 12(8), 620-636.
11. Steel, B.J. Skin cancer - an overview for dentists. Br. Dent. J., 2014, 216(10), 575-581.
12. Kadakia, K.C.; Barton, D.L.; Loprinzi, C.L.; Sloan, J.A.; Otley, C.C.; Diekmann, B.B.; Novotny, P.J.; Alberts, S.R.; Limburg, P.J.; Pittelkow, M.R. Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251). Cancer, 2012, 118(8), 2128-2137.
13. Onajin, O.; Wetter, D.A.; Roenigk, R.K.; Gibson, L.E.; Weaver, A.L.; Comfere, N.I. Frozen section diagnosis for non-melanoma skin cancers: correlation with permanent section diagnosis. J. Cutan. Pathol., 2015, 42(7), 459-464.
14. Reichrath, J. Sunlight, Vitamin D and Skin Cancer; Springer, 2014.
15. McCusker, M.; Basset-Seguin, N.; Dummer, R.; Lewis, K.; Schadendorf, D.; Sekulic, A.; Hou, J.; Wang, L.; Yue, H.; Hauschild, A. Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease. Eur. J. Cancer, 2014, 50(4), 774-783.
16. Narayanan, D.L.; Saladi, R.N.; Fox, J.L. Ultraviolet radiation and skin cancer. Int. J. Dermatol., 2010, 49(9), 978-986.
17. Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bray, F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer, 2015, 136(5), E359-E386.
18. American Cancer Society. Cancer Facts and Figures, 2016.
19. Riou-Gotta, M-O.; Fournier, E.; Danzon, A.; Pelletier, F.; Levang, J.; Mermet, I.; Blanc, D.; Humbert, P.; Aubin, F. Rare skin cancer: a population-based cancer registry descriptive study of 151 consecutive cases diagnosed between 1980 and 2004. Acta Oncol., 2009, 48(4), 605-609.
20. Leiter, U. Eigentler, T.; Garbe, C. Sunlight, Vitamin D. and Skin Cancer; Springer, 2014; pp. 120-140.
21. Skin cancers: how common is skin cancer. In: Ultraviolet radiation and the INTERSUN Programme http://www.who. int/uv/faq/skincancer/en/index1.html
22. Johnson, F.E.; Maehara, Y.; Browman, G.P.; Margenthaler, J.A.; Audisio, R.A.; Thompson, J.F.; Johnson, D.Y.; Earle, C.C.; Virgo, K. Patient Surveillance After Cancer Treatment; Springer Science & Business Media, 2013.
23. Hu, S.; Parmet, Y.; Allen, G.; Parker, D.F.; Ma, F.; Rouhani, P.; Kirsner, R.S. Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida. Arch. Dermatol., 2009, 145(12), 1369-1374.
24. Surdu, S.; Fitzgerald, E.F.; Bloom, M.S.; Boscoe, F.P.; Carpenter, D.O.; Haase, R.F.; Gurzau, E.; Rudnai, P.; Koppova, K.; Fevotte, J.; Leonardi, G.; Vahter, M.; Goessler, W.; Kumar, R.; Fletcher, T. Occupational exposure to ultraviolet radiation and risk of non-melanoma skin cancer in a multinational European study. PLoS One, 2013, 8(4), e62359.
25. Korgavkar, K.; Lee, K.C.; Weinstock, M.A. Higher melanoma incidence in coastal versus inland counties in California. Melanoma Res., 2014, 24(3), 280-285.
26. Moan, J.; Grigalavicius, M.; Baturaite, Z.; Dahlback, A.; Juzeniene, A. The relationship between UV exposure and incidence of skin cancer. Photodermatol. Photoimmunol. Photomed., 2015, 31(1), 26-35.
27. Lee, C.H.; Wu, S.B.; Hong, C.H.; Yu, H.S.; Wei, Y.H. Molecular mechanisms of UV-induced apoptosis and its effects on skin residential cells: the implication in UVbased phototherapy. Int. J. Mol. Sci., 2013, 14(3), 6414-6435.
28. Sies, H. Oxidative Stress; Elsevier, 2013.
29. Gordon, R. In Seminars in Oncology Nursing; Elsevier, 2013, Vol. 29, pp. 160-169.
30. Hensler, S.; Mueller, M.M. Inflammation and skin cancer: old pals telling new stories. Cancer J., 2013, 19(6), 517-524.
31. Kolodecik, T.; Shugrue, C.; Ashat, M.; Thrower, E.C. Risk factors for pancreatic cancer: underlying mechanisms and potential targets. Front. Physiol., 2013, 4, 415.
32. Gerlini, G.; Romagnoli, P.; Pimpinelli, N. Skin cancer and immunosuppression. Crit. Rev. Oncol. Hematol., 2005, 56(1), 127-136.
33. Pasparakis, M.; Haase, I.; Nestle, F.O. Mechanisms regulating skin immunity and inflammation. Nat. Rev. Immunol., 2014, 14(5), 289-301.
34. Lund, A.W.; Medler, T.R.; Leachman, S.A.; Coussens, L.M. Lymphatic vessels, inflammation, and immunity in skin cancer. Cancer Discov., 2016, 6(1), 22-35.
35. Kupper, T.S.; Fuhlbrigge, R.C. Immune surveillance in the skin: mechanisms and clinical consequences. Nat. Rev. Immunol., 2004, 4(3), 211-222.
36. Poljšak, B.; Fink, R. The protective role of antioxidants in the defence against ROS/RNS-mediated environmental pollution. Oxid. Med. Cell. Longev., 2014, 2014, 671539.
37. Jiao, J.; Mikulec, C.; Ishikawa, T.O.; Magyar, C.; Dumlao, D.S.; Dennis, E.A.; Fischer, S.M.; Herschman, H. Celltype-specific roles for COX-2 in UVB-induced skin cancer. Carcinogenesis, 2014, 35(6), 1310-1319.
38. Dupont, E.; Gomez, J.; Bilodeau, D. Beyond UV radiation: a skin under challenge. Int. J. Cosmet. Sci., 2013, 35(3), 224-232.
39. Oeckinghaus, A.; Ghosh, S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol., 2009, 1(4), a000034.
40. Goodman, J.R.; Grossman, D. Aspirin and other NSAIDs as chemoprevention agents in melanoma. Cancer Prev. Res. (Phila.), 2014, 7(6), 557-564.
41. Chen, H.; Yao, K.; Nadas, J.; Bode, A.M.; Malakhova, M.; Oi, N.; Li, H.; Lubet, R.A.; Dong, Z. Prediction of molecular targets of cancer preventing flavonoid compounds using computational methods. PLoS One, 2012, 7(5), e38261.
42. Kim, H.P.; Son, K.H.; Chang, H.W.; Kang, S.S. Antiinflammatory plant flavonoids and cellular action mechanisms. J. Pharmacol. Sci., 2004, 96(3), 229-245.
43. Sekhon-Loodu, S.; Catalli, A.; Kulka, M.; Wang, Y.; Shahidi, F.; Rupasinghe, H.P. Apple flavonols and n-3 polyunsaturated fatty acid-rich fish oil lowers blood C-reactive protein in rats with hypercholesterolemia and acute inflammation. Nutr. Res., 2014, 34(6), 535-543.
44. Keddy, P.G.; Dunlop, K.; Warford, J.; Samson, M.L.; Jones, Q.R.; Rupasinghe, H.P.; Robertson, G.S. Neuroprotective and anti-inflammatory effects of the flavonoidenriched fraction AF4 in a mouse model of hypoxicischemic brain injury. PLoS One, 2012, 7(12), e51324.
45. Shukla, S.; Gupta, S. Apigenin: a promising molecule for cancer prevention. Pharm. Res., 2010, 27(6), 962-978.
46. Byun, S.; Park, J.; Lee, E.; Lim, S.; Yu, J.G.; Lee, S.J.; Chen, H.; Dong, Z.; Lee, K.W.; Lee, H.J. Src kinase is a direct target of apigenin against UVB-induced skin inflammation. Carcinogenesis, 2013, 34(2), 397-405.
47. Byun, S.; Lee, K.W.; Jung, S.K.; Lee, E.J.; Hwang, M.K.; Lim, S.H.; Bode, A.M.; Lee, H.J.; Dong, Z. Luteolin inhibits protein kinase C(∈) and c-Src activities and UVBinduced skin cancer. Cancer Res., 2010, 70(6), 2415-2423.
48. Saewan, N.; Jimtaisong, A. Photoprotection of natural flavonoids. J. Appl. Pharmaceut. Sci., 2013, 3(09), 129-141.
49. Sanson, M.; Distel, E.; Fisher, E.A. HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process. PLoS One, 2013, 8(8), e74676.
50. Kim, S.H.; Park, J.G.; Lee, J.; Yang, W.S.; Park, G.W.; Kim, H.G.; Yi, Y.S.; Baek, K.S.; Sung, N.Y.; Hossen, M.J.; Lee, M.N.; Kim, J.H.; Cho, J.Y. The dietary flavonoid Kaempferol mediates anti-inflammatory responses via the Src, Syk, IRAK1, and IRAK4 molecular targets. Mediators Inflamm., 2015, 2015, 904142.
51. Pal, H.C.; Athar, M.; Elmets, C.A.; Afaq, F. Fisetin inhibits UVB-induced cutaneous inflammation and activation of PI3K/AKT/NFκB signaling pathways in SKH-1 hairless mice. Photochem. Photobiol., 2015, 91(1), 225-234.
52. Shay, J.; Elbaz, H.A.; Lee, I.; Zielske, S.P.; Malek, M.H.; Huttemann, M. Molecular mechanisms and therapeutic effects of (-)-epicatechin and other polyphenols in cancer, inflammation, diabetes, and neurodegeneration. Oxid. Med. Cell. Longev., 2015, 2015, 181260.
53. Asadi, S.Y.; Parsaei, P.; Karimi, M.; Ezzati, S.; Zamiri, A.; Mohammadizadeh, F.; Rafieian-Kopaei, M. Effect of green tea (Camellia sinensis) extract on healing process of surgical wounds in rat. Int. J. Surg., 2013, 11(4), 332-337.
54. Clarke, K.A.; Dew, T.P.; Watson, R.E.; Farrar, M.D.; Osman, J.E.; Nicolaou, A.; Rhodes, L.E.; Williamson, G. Green tea catechins and their metabolites in human skin before and after exposure to ultraviolet radiation. J. Nutr. Biochem., 2016, 27, 203-210.
55. Rhodes, L.E.; Darby, G.; Massey, K.A.; Clarke, K.A.; Dew, T.P.; Farrar, M.D.; Bennett, S.; Watson, R.E.; Williamson, G.; Nicolaou, A. Oral green tea catechin metabolites are incorporated into human skin and protect against UV radiation-induced cutaneous inflammation in association with reduced production of pro-inflammatory eicosanoid 12-hydroxyeicosatetraenoic acid. Br. J. Nutr., 2013, 110(5), 891-900.
56. Li, N.; Deng, L.; Xiang, L.; Liang, Y. Photoprotective effect of tea and its extracts against ultraviolet radiationinduced skin disorders. Trop. J. Pharm. Res., 2014, 13(3), 475-483.
57. Yin, Y.; Li, W.; Son, Y.O.; Sun, L.; Lu, J.; Kim, D.; Wang, X.; Yao, H.; Wang, L.; Pratheeshkumar, P.; Hitron, A.J.; Luo, J.; Gao, N.; Shi, X.; Zhang, Z. Quercitrin protects skin from UVB-induced oxidative damage. Toxicol. Appl. Pharmacol., 2013, 269(2), 89-99.
58. Martinez, R.M.; Pinho-Ribeiro, F.A.; Steffen, V.S.; Silva, T.C.; Caviglione, C.V.; Bottura, C.; Fonseca, M.J.; Vicentini, F.T.; Vignoli, J.A.; Baracat, M.M.; Georgetti, S.R.; Verri, W.A., Jr; Casagrande, R. Topical Formulation Containing Naringenin: Efficacy against ultraviolet b irradiation-induced skin inflammation and oxidative stress in mice. PLoS One, 2016, 11(1), e0146296.
59. Martinez, R.M.; Pinho-Ribeiro, F.A.; Steffen, V.S.; Caviglione, C.V.; Vignoli, J.A.; Baracat, M.M.; Georgetti, S.R.; Verri, W.A., Jr; Casagrande, R. Hesperidin methyl chalcone inhibits oxidative stress and inflammation in a mouse model of ultraviolet B irradiation-induced skin damage. J. Photochem. Photobiol. B, 2015, 148, 145-153.
60. Gosslau, A.; Chen, K.Y.; Ho, C.T.; Li, S. Antiinflammatory effects of characterized orange peel extracts enriched with bioactive polymethoxyflavones. Food Sc. Human Wellness, 2014, 3(1), 26-35.
61. Lai, C.S.; Li, S.; Chai, C.Y.; Lo, C.Y.; Ho, C.T.; Wang, Y.J.; Pan, M.H. Inhibitory effect of citrus 5-hydroxy-3,6,7,8,3′,4′-hexamethoxyflavone on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice. Carcinogenesis, 2007, 28(12), 2581-2588.
62. Beasley, S.; El-Sherbiny, M.; Megyerdi, S.; El-Shafey, S.; Choksi, K.; Kaddour-Djebbar, I.; Sheibani, N.; Hsu, S.; Al-Shabrawey, M. Caspase-14 expression impairs retinal pigment epithelium barrier function: potential role in diabetic macular edema. BioMed. Res. Int., 2014, 2014, 417986.
63. Kam, D.W.; Charles, A.K.; Dharmarajan, A.M. Caspase-14 expression in the human placenta. Reprod. Biomed. Online, 2005, 11(2), 236-243.
64. White, L.J.; Declercq, W.; Arfuso, F.; Charles, A.K.; Dharmarajan, A.M. Function of caspase-14 in trophoblast differentiation. Reprod. Biol. Endocrinol., 2009, 7(1), 98.
65. Lemound, J.; Stucki-Koch, A.; Stoetzer, M.; Kokemuller, H.; Gellrich, N.C.; Kreipe, H.; Hussein, K. Aberrant expression of caspase 14 in salivary gland carcinomas. J. Oral Pathol. Med., 2015, 44(6), 444-448.
66. Raymond, A.A.; Mechin, M.C.; Nachat, R.; Toulza, E.; Tazi-Ahnini, R.; Serre, G.; Simon, M. Nine procaspases are expressed in normal human epidermis, but only caspase-14 is fully processed. Br. J. Dermatol., 2007, 156(3), 420-427.
67. Kubo, A.; Nagao, K.; Amagai, M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J. Clin. Invest., 2012, 122(2), 440-447.
68. McIlwain, D.R.; Berger, T.; Mak, T.W. Caspase functions in cell death and disease. Cold Spring Harb. Perspect. Biol., 2013, 5(4), a008656.
69. Hsu, S.; Dickinson, D.; Borke, J.; Walsh, D.S.; Wood, J.; Qin, H.; Winger, J.; Pearl, H.; Schuster, G.; Bollag, W.B. Green tea polyphenol induces caspase 14 in epidermal keratinocytes via MAPK pathways and reduces psoriasiform lesions in the flaky skin mouse model. Exp. Dermatol., 2007, 16(8), 678-684.
70. George, V.C.; Kumar, D.R.; Suresh, P.K.; Kumar, R.A. Luteolin induces caspase-14-mediated terminal differentiation in human epidermal keratinocytes. In Vitro Cell. Dev. Biol. Anim., 2015, 51(10), 1072-1076.
71. Brown, S.J.; McLean, W.H. One remarkable molecule: filaggrin. J. Invest. Dermatol., 2012, 132(3 Pt 2), 751-762.
72. Sandilands, A.; Sutherland, C.; Irvine, A.D.; McLean, W.H. Filaggrin in the frontline: role in skin barrier function and disease. J. Cell Sci., 2009, 122(Pt 9), 1285-1294.
73. Hoste, E.; Kemperman, P.; Devos, M.; Denecker, G.; Kezic, S.; Yau, N.; Gilbert, B.; Lippens, S.; De Groote, P.; Roelandt, R.; Van Damme, P.; Gevaert, K.; Presland, R.B.; Takahara, H.; Puppels, G.; Caspers, P.; Vandenabeele, P.; Declercq, W. Caspase-14 is required for filaggrin degradation to natural moisturizing factors in the skin. J. Invest. Dermatol., 2011, 131(11), 2233-2241.
74. Kim, B.; Choi, Y.E.; Kim, H.S. Eruca sativa and its flavonoid components, quercetin and isorhamnetin, improve skin barrier function by activation of peroxisome proliferator-activated receptor (PPAR)-α and suppression of inflammatory cytokines. Phytother. Res., 2014, 28(9), 1359-1366.
75. Shukla, G.C.; Singh, J.; Barik, S. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol. Cell. Pharmacol., 2011, 3(3), 83-92.
76. Lin, S.; Gregory, R.I. MicroRNA biogenesis pathways in cancer. Nat. Rev. Cancer, 2015, 15(6), 321-333.
77. Syed, D.N.; Khan, M.I.; Shabbir, M.; Mukhtar, H. MicroRNAs in skin response to UV radiation. Curr. Drug Targets, 2013, 14(10), 1128-1134.
78. Poell, J.B.; van Haastert, R.J.; de Gunst, T.; Schultz, I.J.; Gommans, W.M.; Verheul, M.; Cerisoli, F.; van Noort, P.I.; Prevost, G.P.; Schaapveld, R.Q.; Cuppen, E. A functional screen identifies specific microRNAs capable of inhibiting human melanoma cell viability. PLoS One, 2012, 7(8), e43569.
79. Sand, M.; Gambichler, T.; Sand, D.; Skrygan, M.; Altmeyer, P.; Bechara, F.G. MicroRNAs and the skin: tiny players in the body's largest organ. J. Dermatol. Sci., 2009, 53(3), 169-175.
80. Srivastava, S.K.; Arora, S.; Averett, C.; Singh, S.; Singh, A.P. Modulation of microRNAs by phytochemicals in cancer: underlying mechanisms and translational significance. BioMed Res. Int., 2015, 2015, 848710.
81. Shah, M.S.; Davidson, L.A.; Chapkin, R.S. Mechanistic insights into the role of microRNAs in cancer: influence of nutrient crosstalk. Front. Genet., 2012, 3(305), 305.
82. Lancon, A.; Michaille, J.J.; Latruffe, N. Effects of dietary phytophenols on the expression of microRNAs involved in mammalian cell homeostasis. J. Sci. Food Agric., 2013, 93(13), 3155-3164.
83. An, I-S.; An, S.; Park, S.; Lee, S.N.; Bae, S. Involvement of microRNAs in epigallocatechin gallate-mediated UVB protection in human dermal fibroblasts. Oncol. Rep., 2013, 29(1), 253-259.
84. Milenkovic, D.; Jude, B.; Morand, C. miRNA as molecular target of polyphenols underlying their biological effects. Free Radic. Biol. Med., 2013, 64, 40-51.
85. Saini, S.; Arora, S.; Majid, S.; Shahryari, V.; Chen, Y.; Deng, G.; Yamamura, S.; Ueno, K.; Dahiya, R. Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev. Res. (Phila.), 2011, 4(10), 1698-1709.
86. Dahmke, I.N.; Backes, C.; Rudzitis-Auth, J.; Laschke, M.W.; Leidinger, P.; Menger, M.D.; Meese, E.; Mahlknecht, U. Curcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly altered. PLoS One, 2013, 8(12), e81122.
87. Leonard, M.K.; Kommagani, R.; Payal, V.; Mayo, L.D.; Shamma, H.N.; Kadakia, M.P. ΔNp63α regulates keratinocyte proliferation by controlling PTEN expression and localization. Cell Death Differ., 2011, 18(12), 1924-1933.
88. Rethi, B.; Eidsmo, L. FasL and TRAIL signaling in the skin during cutaneous leishmaniasis - implications for tissue immunopathology and infectious control. Front. Immunol., 2012, 3, 163.
89. Skaaby, T.; Husemoen, L.L.; Thyssen, J.P.; Meldgaard, M.; Thuesen, B.H.; Pisinger, C.; Jorgensen, T.; Carlsen, K.; Johansen, J.D.; Menne, T.; Szecsi, P.B.; Stender, S.; Linneberg, A. Filaggrin loss-of-function mutations and incident cancer: a population-based study. Br. J. Dermatol., 2014, 171(6), 1407-1414.
90. Sonkoly, E.; Wei, T.; Janson, P.C.; Saaf, A.; Lundeberg, L.; Tengvall-Linder, M.; Norstedt, G.; Alenius, H.; Homey, B.; Scheynius, A.; Stahle, M.; Pivarcsi, A. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One, 2007, 2(7), e610.
91. Murakami, A.; Nakamura, Y.; Torikai, K.; Tanaka, T.; Koshiba, T.; Koshimizu, K.; Kuwahara, S.; Takahashi, Y.; Ogawa, K.; Yano, M.; Tokuda, H.; Nishino, H.; Mimaki, Y.; Sashida, Y.; Kitanaka, S.; Ohigashi, H. Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res., 2000, 60(18), 5059-5066.
92. Ragab, E.A. Highly methoxylated flavonoids and the antieczematous activity of Rhamnus disperma roots. J. Pharmacogn. Phytochem., 2015, 4(3), 1-8.
93. Xia, J.; Zhang, W. MicroRNAs in normal and psoriatic skin. Physiol. Genomics, 2014, 46(4), 113-122.
94. Vijayalakshmi, A.; Ravichandiran, V.; Malarkodi, V.; Nirmala, S.; Jayakumari, S. Screening of flavonoid "quercetin" from the rhizome of Smilax china Linn. for anti-psoriatic activity. Asian Pac. J. Trop. Biomed., 2012, 2(4), 269-275.
95. Geetha, M. Anti-psoriatic activity of flavonoids from Cassia tora leaves using the rat ultraviolet B ray photodermatitis model. Revista Brasileira de Farmacognosia, 2014, 24(3), 322-329.
96. Lippens, S.; Kockx, M.; Denecker, G.; Knaapen, M.; Verheyen, A.; Christiaen, R.; Tschachler, E.; Vandenabeele, P.; Declercq, W.; Vitamin, D. Vitamin D3 induces caspase-14 expression in psoriatic lesions and enhances caspase-14 processing in organotypic skin cultures. Am. J. Pathol., 2004, 165(3), 833-841.
97. Steward, W.P.; Brown, K. Cancer chemoprevention: a rapidly evolving field. Br. J. Cancer, 2013, 109(1), 1-7.
98. Rawson, N.E.; Ho, C.T.; Li, S. Efficacious anti-cancer property of flavonoids from citrus peels. Food Sci. Human Wellness, 2014, 3(3), 104-109.
99. Horwitz, S.B.; Cohen, D.; Rao, S.; Ringel, I.; Shen, H-J.; Yang, C.P. Taxol: mechanisms of action and resistance. J. Natl. Cancer Inst. Monogr., 1993, (15), 55-61.
100. Batra, P.; Sharma, A.K. Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech, 2013, 3(6), 439-459.
101. Harvey, A.L.; Edrada-Ebel, R.; Quinn, R.J. The reemergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov., 2015, 14(2), 111-129.
102. Vogt, T. Phenylpropanoid biosynthesis. Mol. Plant, 2010, 3(1), 2-20.
103. Singh, T.; Katiyar, S.K. Green tea polyphenol, (-)- epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting β-catenin signaling. Toxicol. Appl. Pharmacol., 2013, 273(2), 418-424.
104. Singh, M.; Suman, S.; Shukla, Y. New enlightenment of skin cancer chemoprevention through phytochemicals: In vitro and in vivo studies and the underlying mechanisms. BioMed Res. Int., 2014, 2014, 243452.
105. Vayalil, P.K.; Elmets, C.A.; Katiyar, S.K. Treatment of green tea polyphenols in hydrophilic cream prevents UVBinduced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis, 2003, 24(5), 927-936.
106. George, V.C.; Naveen Kumar, D.R.; Suresh, P.K.; Kumar, S.; Kumar, R.A. Comparative studies to evaluate relative in vitro potency of luteolin in inducing cell cycle arrest and apoptosis in HaCaT and A375 cells. Asian Pac. J. Cancer Prev., 2013, 14(2), 631-637.
107. Lim, S.H.; Jung, S.K.; Byun, S.; Lee, E.J.; Hwang, J.A.; Seo, S.G.; Kim, Y.A.; Yu, J.G.; Lee, K.W.; Lee, H.J. Luteolin suppresses UVB-induced photoageing by targeting JNK1 and p90 RSK2. J. Cell. Mol. Med., 2013, 17(5), 672-680.
108. Ruan, J.S.; Liu, Y.P.; Zhang, L.; Yan, L.G.; Fan, F.T.; Shen, C.S.; Wang, A.Y.; Zheng, S.Z.; Wang, S.M.; Lu, Y. Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelialmesenchymal transition. Acta Pharmacol. Sin., 2012, 33(10), 1325-1331.
109. Baumann, L.S. Less-known botanical cosmeceuticals. Dermatol. Ther. (Heidelb.), 2007, 20(5), 330-342.
110. Paredes-Gonzalez, X.; Fuentes, F.; Su, Z-Y.; Kong, A-N. Apigenin reactivates Nrf2 anti-oxidative stress signaling in mouse skin epidermal JB6 P + cells through epigenetics modifications. AAPS J., 2014, 16(4), 727-735.
111. Hasnat, M.A.; Pervin, M.; Lim, J.H.; Lim, B.O. Apigenin attenuates melanoma cell migration by inducing anoikis through integrin and focal adhesion kinase inhibition. Molecules, 2015, 20(12), 21157-21166.
112. Bridgeman, B.B.; Wang, P.; Ye, B.; Pelling, J.C.; Volpert, O.V.; Tong, X. Inhibition of mTOR by apigenin in UVBirradiated keratinocytes: A new implication of skin cancer prevention. Cell. Signal., 2016, 28(5), 460-468.
113. Liu, H.; Liu, K.; Huang, Z.; Park, C-M.; Thimmegowda, N.R.; Jang, J-H.; Ryoo, I-J.; He, L.; Kim, S-O.; Oi, N.; Lee, K.W.; Soung, N.K.; Bode, A.M.; Yang, Y.; Zhou, X.; Erikson, R.L.; Ahn, J.S.; Hwang, J.; Kim, K.E.; Dong, Z.; Kim, B.Y. A chrysin derivative suppresses skin cancer growth by inhibiting cyclin-dependent kinases. J. Biol. Chem., 2013, 288(36), 25924-25937.
114. Liu, H.; Hwang, J.; Li, W.; Choi, T.W.; Liu, K.; Huang, Z.; Jang, J-H.; Thimmegowda, N.R.; Lee, K.W.; Ryoo, I-J.; Ahn, J.S.; Bode, A.M.; Zhou, X.; Yang, Y.; Erikson, R.L.; Kim, B.Y.; Dong, Z. A derivative of chrysin suppresses two-stage skin carcinogenesis by inhibiting mitogen- and stress-activated kinase 1. Cancer Prev. Res. (Phila.), 2014, 7(1), 74-85.
115. Huang, C.; Chen, Y.J.; Chen, W.J.; Lin, C.L.; Wei, Y.X.; Huang, H.C. Combined treatment with chrysin and 1,2,3,4,6-penta-O-galloyl-β-D-glucose synergistically inhibits LRP6 and Skp2 activation in triple-negative breast cancer and xenografts. Mol. Carcinog., 2015, 54(12), 1613-1625.
116. Lee, K.M.; Lee, K.W.; Jung, S.K.; Lee, E.J.; Heo, Y-S.; Bode, A.M.; Lubet, R.A.; Lee, H.J.; Dong, Z. Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity. Biochem. Pharmacol., 2010, 80(12), 2042-2049.
117. Olszewska, M. Separation of quercetin, sexangularetin, kaempferol and isorhamnetin for simultaneous HPLC determination of flavonoid aglycones in inflorescences, leaves and fruits of three Sorbus species. J. Pharm. Biomed. Anal., 2008, 48(3), 629-635.
118. Yao, K.; Chen, H.; Liu, K.; Langfald, A.; Yang, G.; Zhang, Y.; Yu, D.H.; Kim, M.O.; Lee, M-H.; Li, H.; Bae, K.B.; Kim, H.G.; Ma, W.Y.; Bode, A.M.; Dong, Z.; Dong, Z. Kaempferol targets RSK2 and MSK1 to suppress UV radiation-induced skin cancer. Cancer Prev. Res. (Phila.), 2014, 7(9), 958-967.
119. Uzarska, M.; Czajkowski, R.; Schwartz, R.A.; Bajek, A.; Zegarska, B.; Drewa, T. Chemoprevention of skin melanoma: facts and myths. Melanoma Res., 2013, 23(6), 426-433.
120. Deep, G.; Agarwal, R. Chemopreventive efficacy of silymarin in skin and prostate cancer. Integr. Cancer Ther., 2007, 6(2), 130-145.
121. Singh, R.P.; Agarwal, R. Flavonoid antioxidant silymarin and skin cancer. Antioxid. Redox Signal., 2002, 4(4), 655-663.
122. Martinez, R.M.; Pinho-Ribeiro, F.A.; Steffen, V.S.; Caviglione, C.V.; Vignoli, J.A.; Barbosa, D.S.; Baracat, M.M.; Georgetti, S.R.; Verri, W.A., Jr; Casagrande, R.; Naringenin Inhibits, U.V. Naringenin Inhibits UVB Irradiation-Induced Inflammation and Oxidative Stress in the Skin of Hairless Mice. J. Nat. Prod., 2015, 78(7), 1647-1655.
123. Russo, M.; Spagnuolo, C.; Tedesco, I.; Bilotto, S.; Russo, G.L. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem. Pharmacol., 2012, 83(1), 6-15.
124. Mendoza, E.E.; Burd, R. Quercetin as a systemic chemopreventative agent: structural and functional mechanisms. Mini Rev. Med. Chem., 2011, 11(14), 1216-1221.
125. Middleton, E., Jr; Kandaswami, C.; Theoharides, T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 2000, 52(4), 673-751.
126. Caltagirone, S.; Rossi, C.; Poggi, A.; Ranelletti, F.O.; Natali, P.G.; Brunetti, M.; Aiello, F.B.; Piantelli, M. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int. J. Cancer, 2000, 87(4), 595-600.
127. Piantelli, M.; Rossi, C.; Iezzi, M.; La Sorda, R.; Iacobelli, S.; Alberti, S.; Natali, P.G. Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. J. Cell. Physiol., 2006, 207(1), 23-29.
128. Zhang, X.M.; Chen, J.; Xia, Y.G.; Xu, Q. Apoptosis of murine melanoma B16-BL6 cells induced by quercetin targeting mitochondria, inhibiting expression of PKC-α and translocating PKC-δ. Cancer Chemother. Pharmacol., 2005, 55(3), 251-262.
129. Qin, Y.; He, L.; Chen, Y.; Wang, W.; Zhao, X.; Wu, M. Quercetin affects leptin and its receptor in human gastric cancer MGC-803 cells and JAK-STAT pathway. Chin. J. Cell. Mol. Immunol., 2012, 28(1), 12-16.
130. Cao, H.H.; Tse, A.K.; Kwan, H.Y.; Yu, H.; Cheng, C.Y.; Su, T.; Fong, W.F.; Yu, Z.L. Quercetin exerts antimelanoma activities and inhibits STAT3 signaling. Biochem. Pharmacol., 2014, 87(3), 424-434.
131. Maas, M.; Deters, A.M.; Hensel, A. Anti-inflammatory activity of Eupatorium perfoliatum L. extracts, eupafolin, and dimeric guaianolide via iNOS inhibitory activity and modulation of inflammation-related cytokines and chemokines. J. Ethnopharmacol., 2011, 137(1), 371-381.
132. Lai, Z.R.; Ho, Y.L.; Huang, S.C.; Huang, T.H.; Lai, S.C.; Tsai, J.C.; Wang, C.Y.; Huang, G.J.; Chang, Y.S. Antioxidant, anti-inflammatory and antiproliferative activities of Kalanchoe gracilis (L.) DC stem. Am. J. Chin. Med., 2011, 39(6), 1275-1290.
133. Abe, F.; Nagao, T.; Okabe, H. Antiproliferative constituents in plants 9. Aerial parts of Lippia dulcis and Lippia canescens. Biol. Pharm. Bull., 2002, 25(7), 920-922.
134. Ko, H.H.; Tsai, Y.T.; Yen, M.H.; Lin, C.C.; Liang, C.J.; Yang, T.H.; Lee, C.W.; Yen, F.L. Norartocarpetin from a folk medicine Artocarpus communis plays a melanogenesis inhibitor without cytotoxicity in B16F10 cell and skin irritation in mice. BMC Complement. Altern. Med., 2013, 13(1), 348.
135. He, G.; Pei, G.; Zhou, T.; Zhou, X. Determination of total flavonoids and dihydromyricetin in Ampelopsis grossedentala (Hand-Mazz) WT Wang. China J. Chin. Materia Med., 2000, 25(7), 423-425.
136. Du, Q.; Cai, W.; Xia, M.; Ito, Y. Purification of (+)- dihydromyricetin from leaves extract of Ampelopsis grossedentata using high-speed countercurrent chromatograph with scale-up triple columns. J. Chromatogr. A, 2002, 973(1-2), 217-220.
137. Zhong, Z.X.; Qin, J.P.; Zhou, G.F.; Chen, X.F. Experimental studies of hypoglycemic action on total flavone of Ampelopsis grossedentata from Guangxi. China J. Chin. Mater. Med., 2002, 27(9), 687-689.
138. Zhang, Y.; Ning, Z.; Yang, S.; Wu, H. Antioxidation properties and mechanism of action of dihydromyricetin from Ampelopsis grossedentata. Yao xue xue bao= Acta pharmaceutica Sinica, 2003, 38(4), 241-244.
139. Murakami, T.; Miyakoshi, M.; Araho, D.; Mizutani, K.; Kambara, T.; Ikeda, T.; Chou, W.H.; Inukai, M.; Takenaka, A.; Igarashi, K. Hepatoprotective activity of tocha, the stems and leaves of Ampelopsis grossedentata, and ampelopsin. Biofactors, 2004, 21(1-4), 175-178.
140. Qi, S.; Xin, Y.; Guo, Y.; Diao, Y.; Kou, X.; Luo, L.; Yin, Z. Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways. Int. Immunopharmacol., 2012, 12(1), 278-287.
141. Gao, Q.; Yang, X.; Ou, M. Effect of serum containing tengcha total flavonoid and dihydromyricetin on proliferation and apoptosis of HepG2 cells. China J. Chin. Mater. Med., 2011, 36(4), 500-503.
142. Liu, D.; Luo, M. Study on inhibitory effect of ampelopsin on melanoma by serologic pharmacological method. J. Chin. Med. Mater., 2001, 24(5), 348-350.
143. Zeng, G.; Liu, J.; Chen, H.; Liu, B.; Zhang, Q.; Li, M.; Zhu, R. Dihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cells. Oncol. Rep., 2014, 31(6), 2713-2719.
144. Arai, Y.; Watanabe, S.; Kimira, M.; Shimoi, K.; Mochizuki, R.; Kinae, N. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J. Nutr., 2000, 130(9), 2243-2250.
145. Hanneken, A.; Lin, F.F.; Johnson, J.; Maher, P. Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death. Invest. Ophthalmol. Vis. Sci., 2006, 47(7), 3164-3177.
146. Syed, D.N.; Afaq, F.; Maddodi, N.; Johnson, J.J.; Sarfaraz, S.; Ahmad, A.; Setaluri, V.; Mukhtar, H. Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels. J. Invest. Dermatol., 2011, 131(6), 1291-1299.
147. Suh, Y.; Afaq, F.; Johnson, J.J.; Mukhtar, H. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways. Carcinogenesis, 2009, 30(2), 300-307.
148. Ying, T.H.; Yang, S.F.; Tsai, S.J.; Hsieh, S.C.; Huang, Y.C.; Bau, D.T.; Hsieh, Y.H. Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1/2-mediated activation of caspase-8-/caspase-3-dependent pathway. Arch. Toxicol., 2012, 86(2), 263-273.
149. 2/M arrest and apoptosis of human epidermoid carcinoma A431 cells: role of mitochondrial membrane potential disruption and consequent caspases activation. Exp. Dermatol., 2013, 22(7), 470-475.
150. Pal, H.C.; Sharma, S.; Strickland, L.R.; Katiyar, S.K.; Ballestas, M.E.; Athar, M.; Elmets, C.A.; Afaq, F. Fisetin inhibits human melanoma cell invasion through promotion of mesenchymal to epithelial transition and by targeting MAPK and NFκB signaling pathways. PLoS One, 2014, 9(1), e86338.
151. Pardee, A.B.; Li, Y.Z.; Li, C.J. Cancer therapy with betalapachone. Curr. Cancer Drug Targets, 2002, 2(3), 227-242.
152. Blanco, E.; Bey, E.A.; Khemtong, C.; Yang, S-G.; Setti-Guthi, J.; Chen, H.; Kessinger, C.W.; Carnevale, K.A.; Bornmann, W.G.; Boothman, D.A.; Gao, J. β-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy. Cancer Res., 2010, 70(10), 3896-3904.
153. Pink, J.J.; Planchon, S.M.; Tagliarino, C.; Varnes, M.E.; Siegel, D.; Boothman, D.A. NAD(P)H:Quinone oxidoreductase activity is the principal determinant of β- lapachone cytotoxicity. J. Biol. Chem., 2000, 275(8), 5416-5424.
154. Siegel, D.; Yan, C.; Ross, D. NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones. Biochem. Pharmacol., 2012, 83(8), 1033-1040.
155. Li, J.Z.; Ke, Y.; Misra, H.P.; Trush, M.A.; Li, Y.R.; Zhu, H.; Jia, Z. Mechanistic studies of cancer cell mitochondriaand NQO1-mediated redox activation of beta-lapachone, a potentially novel anticancer agent. Toxicol. Appl. Pharmacol., 2014, 281(3), 285-293.
156. Song, Y.H.; Sun, H.; Zhang, A.H.; Yan, G.I.; Han, Y.; Wang, X.J. Plant-derived natural products as leads to anticancer drugs. J. Med. Plant Herb. Ther. Res., 2014, 2, 6-15.
157. Chinembiri, T.N.; du Plessis, L.H.; Gerber, M.; Hamman, J.H.; du Plessis, J. Review of natural compounds for potential skin cancer treatment. Molecules, 2014, 19(8), 11679-11721.
158. Ghosh, S.; Sikdar, S.; Mukherjee, A.; Khuda-Bukhsh, A.R. Evaluation of chemopreventive potentials of ethanolic extract of Ruta graveolens against A375 skin melanoma cells in vitro and induced skin cancer in mice in vivo. J. Integr. Med., 2015, 13(1), 34-44.
159. Mundkinajeddu, D.; Sawant, L.P.; Koshy, R.; Akunuri, P.; Singh, V.K.; Mayachari, A.; Sharaf, M.H.; Balasubramanian, M.; Agarwal, A. Development and Validation of High Performance Liquid Chromatography Method for Simultaneous Estimation of Flavonoid Glycosides in Withania somnifera Aerial Parts; ISRN Analytical Chemistry, 2014.
160. Yajarla, V.N.; Nimmanapalli, R.P.; Parikapandla, S.; Gupta, G.; Karnati, R. Anti-inflammatory and Anti-proliferative Properties of Chromolaena odorata Leaf Extracts in Normal and Skin-Cancer Cell Lines. J. Herbs Spices Med. Plants, 2014, 20(4), 359-371.
161. Cattaneo, L.; Cicconi, R.; Mignogna, G.; Giorgi, A.; Mattei, M.; Graziani, G.; Ferracane, R.; Grosso, A.; Aducci, P.; Schinina, M.E.; Marra, M. Anti-proliferative effect of Rosmarinus officinalis L. extract on human melanoma A375 cells. PLoS One, 2015, 10(7), e0132439.
162. Fernandez-Cabezudo, M.J.; El-Kharrag, R.; Torab, F.; Bashir, G.; George, J.A.; El-Taji, H.; al-Ramadi, B.K. Intravenous administration of manuka honey inhibits tumor growth and improves host survival when used in combination with chemotherapy in a melanoma mouse model. PLoS One, 2013, 8(2), e55993.
163. Lin, J.A.; Chen, H.C.; Yen, G.C. The preventive role of breadfruit against inflammation-associated epithelial carcinogenesis in mice. Mol. Nutr. Food Res., 2014, 58(1), 206-210.
164. Cibin, T.R.; Devi, D.G.; Abraham, A. Chemoprevention of two-stage skin cancer in vivo by Saraca asoca. Integr. Cancer Ther., 2012, 11(3), 279-286.
165. Passos, G.F.; Medeiros, R.; Marcon, R.; Nascimento, A.F.; Calixto, J.B.; Pianowski, L.F. The role of PKC/ERK1/2 signaling in the anti-inflammatory effect of tetracyclic triterpene euphol on TPA-induced skin inflammation in mice. Eur. J. Pharmacol., 2013, 698(1-3), 413-420.
166. Millsop, J.W.; Sivamani, R.K.; Fazel, N. Botanical agents for the treatment of nonmelanoma skin cancer. Dermatol. Res. Pract., 2013, 2013, 837152.
167. Farzaei, M.H.; Abdollahi, M.; Rahimi, R. Role of dietary polyphenols in the management of peptic ulcer. World J. Gastroenterol., 2015, 21(21), 6499-6517.
168. Yoshizaki, N.; Fujii, T.; Masaki, H.; Okubo, T.; Shimada, K.; Hashizume, R. Orange peel extract, containing high levels of polymethoxyflavonoid, suppressed UVB-induced COX-2 expression and PGE2 production in HaCaT cells through PPAR-γ activation. Exp. Dermatol., 2014, 23(s1)(Suppl. 1), 18-22.
169. Dianzani, C.; Zara, G.P.; Maina, G.; Pettazzoni, P.; Pizzimenti, S.; Rossi, F.; Gigliotti, C.L.; Ciamporcero, E.S.; Daga, M.; Barrera, G. Drug delivery nanoparticles in skin cancers. BioMed Res. Int., 2014, 2014, 895986.